In non-small cell lung cancer, Xu et al. conducted TGF-β-1-induced EMT experiments and EGF-stimulated ERK1/2 activation and other related experiments confirmed that ENO1 inhibits ERK1/2 phosphorylation to inhibit the EMT process, thereby inhibiting tumor development and metastasis [40]. The gene discussed is MAPK3; the disease is neoplasm.